Zobrazeno 1 - 10
of 116
pro vyhledávání: '"J. Condemi"'
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lorcan P McGarvey, Zhi Jin Xu, Vivek Iyer, James Krainson, James H. Hull, Mark H Gotfried, Jaclyn A Smith, David Muccino, Gary C Steven, Douglas McQuaid, David I. Bernstein, Gregory Daniel Brooks, David Elkayam, Wen-Chi Wu, Selwyn Spangenthal, Mandel R Sher, Jaclyn A. Smith, Yu-Ping Li, John J Condemi, Ellen R Sher, John R Holcomb, W. Carr, Gary N Gross, SM Parker, Gary D Berman, Ratko Djukanovic, Thomas B. Casale, Jason H Friesen, Krishna Sundar, Christopher E. Brightling, Michael Denenberg, Neil Ettinger, S S Birring, Faisal Alfonso Fakih, Bruce M Prenner, Lorcan McGarvey, Niran J Amar, Jonathan Corren, Tim Harrison, Shaila U Gogate, William W. Storms, Alyn H. Morice, Iftikhar Hussain, Leon S Greos, Anthony Montanaro, Anthony P. Ford, James S Good, Eric J Schenkel, Surinder S. Birring, Thomas R Murphy, Michael S Kaplan, William R Lumry, Jonathan Matz, Michael M. Kitt, Mandel Sher, Alan B Goldsobel, Ian D. Pavord
Publikováno v:
Protocol 012 Investigators 2020, ' Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(19)30471-0
BACKGROUND: Gefapixant is a P2X3 receptor antagonist that has shown promise for the treatment of refractory and unexplained chronic cough. The aim of this study was to evaluate the efficacy of gefapixant compared with placebo after 12 weeks of treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed8062bd34a8ad548083ad97ee59fbd
https://pure.qub.ac.uk/en/publications/gefapixant-a-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-randomised-doubleblind-controlled-parallelgroup-phase-2b-trial(5aa94b05-a819-433a-a265-b0ce6c143476).html
https://pure.qub.ac.uk/en/publications/gefapixant-a-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-randomised-doubleblind-controlled-parallelgroup-phase-2b-trial(5aa94b05-a819-433a-a265-b0ce6c143476).html
Autor:
Lilia Pineda, Michael Burnette, Z. John Zhong, Jerry Klein, Jeffrey R. Lisse, James D. McKay, John J. Condemi, Ellen M. Ginzler, Joan T. Merrill, Daniel J. Wallace, Frank R. Wellborne, William W. Freimuth, Cynthia Aranow
Publikováno v:
Arthritis & Rheumatism. 64:3364-3373
Objective To evaluate the safety profile of long-term belimumab therapy combined with standard therapy for systemic lupus erythematosus (SLE) in patients with active disease. Methods Patients who were randomized to receive intravenous placebo or beli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f16d676b8bed1ccf0db2e1366aba4d01
https://doi.org/10.1002/art.34564
https://doi.org/10.1002/art.34564
Autor:
John J. Condemi, Stephanie Ensworth, Mahesh Krishnan, Adrian M. Jaffer, Rosalind Ramsey-Goldman, Bryan C. Pogue, Gary M. Kammer, Claudia Hura, Stanley P. Ballou, James Jakes, Gary S. Gilkeson, Arnold Roth, Daniel J. Wallace, Charles Moritz, Gerald B. Appel, Moses Spira, Carl V. Manion, Michael Becker, Joachim R. Kalden, Naomi F. Rothfield, J.E. Loveless, Yvonne Sherrer, Raphael J. Dehoratius, Stanley B. Kaplan, Christine Kovacs, Douglas Smith, Phillip J. Mease, Michael R. Liebling, Neil A. Kurtzman, Falk Hiepe, John Donohue, Maria Fondal, Thomas D. Geppert, John J. Cush, Paul Howard, Munther A. Khamashta, Jacob A. Aelion, Bruce Spinowitz, William Surbeck, J. L. Granda, Mary E. Cronin, Gunnar Sturfelt, James P. Brodeur, Mario H. Cardiel, James D. McKay, Elizabeth A. Tindall, Robert Quinet, Robert S. Katz, Mariana J. Kaplan, Mohamed A. El-Shahawy, H. Michael Belmont, James A. Tumlin, Luis R. Espinoza, Ronald F van Vollenhoven, Micha Abeles, Susan Manzi, Seth H. Lourie, Alastair C. Kennedy, Moges Sisay, Eugene P. Boling, Matthias Schneider, C. Michael Neuwelt, Larry W. Moreland, Gary W. Williams, Howard M. Kenney, Jean Sibilia, Kevin Martin, Jennifer M. Grossman, Michelle Petri, Richard Furie, Michael Edwards, Ellen M. Ginzler, Michael Zummer, Arnaldo Torres, Jill P. Buyon, Miguel Vilardell-Tarres, Alan Kivitz, Deborah Desir, Tenshang Joh, Matthew D. Linnik, Joan T. Merrill, Paul R. Fortin, Stefano Bombardieri, William Shergy, Anitha Vijayan, Paul Emery, Cynthia Aranow, Nicholas Scarpa, Michael P. Stevens, Cynthia Anderson Weaver, Peter D. Gorevic
Publikováno v:
Arthritis & Rheumatism. 58:2470-2480
Objective To investigate whether treatment with abetimus delays renal flare in patients with lupus nephritis. Secondary objectives included evaluation of the effect of abetimus on C3 levels, anti–double-stranded DNA (anti-dsDNA) antibody levels, us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68249b7352a0b26be453d1d6d92c133
https://doi.org/10.1002/art.23673
https://doi.org/10.1002/art.23673
Autor:
Steven F. Weinstein, Leslie Baitinger, Catherine Scott, David B. Peden, David S. Pearlman, Paul Dorinsky, Karen W. House, Martha V. White, Shu Yen Ho, John J. Condemi
Publikováno v:
Journal of Asthma. 41:797-806
The objective of this study was to compare the efficacy and safety of fluticasone propionate (FP) (44 microg)/salmeterol (21 microg) delivered as two inhalations twice daily via a single hydrofluoroalkane (HFA 134a) metered dose inhaler (MDI) (FSC) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61bcd3a8460eeb9b078b17c570e188b
https://doi.org/10.1081/jas-200038368
https://doi.org/10.1081/jas-200038368
Publikováno v:
Annals of Allergy, Asthma & Immunology. 91:314-317
Background Primary sclerosing cholangitis is an uncommon chronic cholestatic liver disease with a poor prognosis in symptomatic cases. Genetic and immunologic alterations have been identified, and many possible etiologies have been entertained. Most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51baaefea2b5b5545905856216696190
https://doi.org/10.1016/s1081-1206(10)63537-5
https://doi.org/10.1016/s1081-1206(10)63537-5
Autor:
T. Desta, C. Strout, T. Otrok, Ciaran P. Kelly, A. Vento, P. Varunok, Richard N. Fedorak, Annette Marcantonio, Ronald Fogel, M. Reichelderfer, Michael Torbenson, Anthony J. DiMarino, A. Knoll, Peter H.R. Green, M. Wood, Premysl Bercik, Knut Ea Lundin, R. Kotfila, B. Chipps, S. Saini, T. Ritter, Sveta Shah, R. Phillips, B. Bressler, Saqib Hussain Ansari, J. Condemi, M. DeMeo, Vishal S. Chandan, B. Freilich, G. Pyle, S. Freeman, K. Gill, A. Coates, David S Sanders, Daniel C. Adelman, K. Jagarlamundi, V. Cheekati, R. Hardi, T. Welton, Vandana Nehra, R. Wohlman, K. Marks, A. Goldsobel, Joseph A. Murray, C. Corder, J. Kirstein, M. DuPree, C. Behrend, Marjorie F. Goldstein, K. Merkes, V. Narayen, M. Turner, Suzanne K. Lewis, G. Gordon, S. Liakos, S. Woods, C. Ennis, Richard Krause, R. Holmes, Carol E. Semrad, C. Devereaux, A. Basile, K. Ayub, D. Patel, M. Kaplan, J. Goldstein, D. Geenen, B. Reid, D. Suez, J. Oosthuizen, A. Collatrella, Marja-Leena Lähdeaho, M. Lamet, E. Newton, Markku Mäki, M. Kreines, Tsung Teh Wu, A. Nyberg, G. James, Valerie Byrnes, D. Stockwell, K. Yousef, Lucinda A. Harris, Jonathan Corren, A. Kravitz, C. Pepin, S. Moussa, H. Tatum, C. Curtis, K. Laskin, M. Vazquez-Roque, B. Lebwohl, S. Minton, Daniel A. Leffler, K. Friedenberg, M. Schulman
Publikováno v:
Gastroenterology. 152:787-798.e2
Background & Aims Gluten ingestion leads to symptoms and small intestinal mucosal injury in patients with celiac disease. The only option is the strict lifelong exclusion of dietary gluten, which is difficult to accomplish. Many patients following a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387c03feb72edd8ea2519b493304e1ca
https://doi.org/10.1053/j.gastro.2016.11.004
https://doi.org/10.1053/j.gastro.2016.11.004
Publikováno v:
Annals of Allergy, Asthma & Immunology. 84:533-538
The new aqueous formulation of triamcinolone acetonide (TAA) was compared with loratadine in patients with seasonal allergic rhinitis.The primary objective of the study was to compare the safety and efficacy of TAA aqueous with loratadine in relievin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e75158c3bf05b96796694f4b4857bd3
https://doi.org/10.1016/s1081-1206(10)62518-5
https://doi.org/10.1016/s1081-1206(10)62518-5
Publikováno v:
Journal of Allergy and Clinical Immunology. 104:1060-1065
Background: Various forms of Churg-Strauss syndrome have been reported in association with the use of leukotriene receptor antagonists in asthmatic patients. Objective: Our purpose was to increase awareness that different forms of the Churg-Strauss s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10af22870f3bd9ba3d6302d4e4bfb7f8
https://doi.org/10.1016/s0091-6749(99)70089-8
https://doi.org/10.1016/s0091-6749(99)70089-8